T-Cell Cytokines as Predictive Markers of the Risk of Allograft Rejection

免疫抑制 医学 免疫学 移植 药效学 促炎细胞因子 免疫系统 移植排斥反应 代理终结点 药理学 药代动力学 内科学 炎症
作者
Mercé Brunet,Olga Millán López,Marcos López‐Hoyos
出处
期刊:Therapeutic Drug Monitoring [Ovid Technologies (Wolters Kluwer)]
卷期号:38 (Supplement 1): S21-S28 被引量:13
标识
DOI:10.1097/ftd.0000000000000253
摘要

Over the last decade, several biomarkers and surrogate markers have surfaced as promising predictive markers of risk of rejection in solid organ transplantation. The monitoring of these markers can help to improve graft and recipient care by personalizing immunomodulatory therapies. The complex immune system response against an implanted graft can change during long-term follow-up, and the dynamic balance between effector and regulatory T-cell populations is a crucial factor in antidonor response, risk of rejection, and immunosuppression requirements. Therefore, at any time before and after transplantation, T-effector activity, which is associated with increased production and release of proinflammatory cytokines, can be a surrogate marker of the risk of rejection and need for immunosuppression. In addition, immunosuppressive drugs may have a different effect in each individual patient. The pharmacokinetics and pharmacodynamics of these drugs show high interpatient variability, and pharmacodynamic markers, strongly associated with the specific mechanism of action, can potentially be used to measure individual susceptibility to a specific immunosuppressive agent. The monitoring of a panel of valid biomarkers can improve patient stratification and the selection of immunosuppressive drugs. After transplantation, therapy can be adjusted based on the prediction of rejection episodes (maintained alloreactivity), the prognosis of allograft damage, and the individual's response to the drugs. This review will focus on current data indicating that changes in the T-cell production of the intracellular cytokines interferon-γ and interleukin-2 could be used to predict the risk of rejection and to guide immunosuppressive therapy in transplant recipients.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
梁京完成签到,获得积分10
刚刚
刚刚
Hello应助甘草不甜采纳,获得10
刚刚
1秒前
ccCherub完成签到,获得积分10
1秒前
善学以致用应助任新元采纳,获得10
2秒前
李朝富发布了新的文献求助10
2秒前
2秒前
orchid完成签到,获得积分10
2秒前
斯嘉丽发布了新的文献求助10
3秒前
曾经可乐完成签到 ,获得积分10
3秒前
问问大哥完成签到,获得积分10
4秒前
4秒前
Longer完成签到,获得积分10
4秒前
迷路安雁发布了新的文献求助10
4秒前
叮咚雨发布了新的文献求助10
4秒前
4秒前
虚幻心锁发布了新的文献求助10
5秒前
lcr完成签到,获得积分10
5秒前
桐桐应助李朝富采纳,获得10
5秒前
Billy应助FengyaoWang采纳,获得30
5秒前
xiaohe完成签到,获得积分10
6秒前
paparazzi221应助树袋熊采纳,获得100
6秒前
小段发布了新的文献求助20
6秒前
芥末完成签到,获得积分10
6秒前
Ava应助4149采纳,获得10
6秒前
6秒前
星辰大海应助禹平露采纳,获得30
7秒前
啊呜完成签到,获得积分10
8秒前
黑马完成签到,获得积分10
8秒前
8秒前
8秒前
小马甲应助zsg采纳,获得10
8秒前
10秒前
11秒前
11秒前
肖同学完成签到,获得积分10
12秒前
所所应助甘楽采纳,获得10
12秒前
格物致知完成签到,获得积分10
12秒前
申霄九云外完成签到,获得积分20
13秒前
高分求助中
Spray / Wall-interaction Modelling by Dimensionless Data Analysis 2000
ALA生合成不全マウスでの糖代謝異常の分子機構解析 520
安全防范技术与工程 500
2024 Medicinal Chemistry Reviews 400
Актуализированная стратиграфическая схема триасовых отложений Прикаспийского региона. Объяснительная записка 360
Dictionary of socialism 350
AI-Driven Alzheimer's Disease Detection and Prediction 300
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3193321
求助须知:如何正确求助?哪些是违规求助? 2842281
关于积分的说明 8038597
捐赠科研通 2506279
什么是DOI,文献DOI怎么找? 1339013
科研通“疑难数据库(出版商)”最低求助积分说明 638583
邀请新用户注册赠送积分活动 607154